Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Jacob George , Thomas M MacDonald Added: 3 years ago
Hypertension increases the risk of heart attack, stroke, kidney disease, and heart failure1 and is the leading preventable risk factor for global cardiovascular (CV) disease burden worldwide.2 At ages 40–69 years, each increase of 20 mmHg in systolic blood pressure (BP) is associated with more than a doubling of the baseline mortality rate from cardiovascular disease (CVD).3 However, despite the… View more
Author(s): Markus P Schlaich , Murray D Esler Added: 3 years ago
The pathogenesis of primary hypertension is multifactorial. However, the sympathetic nervous system plays an important role in circulatory and metabolic control and has clearly been established as a major contributor to the development of hypertension, with blood pressure elevation being initiated and sustained by elevated sympathetic nervous activity. Increased sympathetic outflow to the heart… View more
Author(s): Zengwu Wang , Tom Richart , Yu Jin , et al Added: 3 years ago
Stroke is the second most common cause of mortality worldwide.1 Cerebrovascular disease caused an estimated 5.7 million deaths in 2005, with 87% occurring in low- or middle-income countries.2 Without intervention, the global number of stroke deaths will rise to 6.5 million in 2015 and 7.8 million in 2030.2 Blood pressure is the most consistent and powerful predictor of stroke. Hypertension… View more
Author(s): Peter M Nilsson Added: 3 years ago
Some cardiovascular (CV) risk-prone patients are easy to recognise, for example following manifestations of cardiovascular disease (CVD), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) interventions, and they deserve appropriate risk-factor control for secondary prevention, including blood pressure (BP) lowering. However, many other at-risk patients… View more
Author(s): Peter M Nilsson Added: 3 years ago
Some cardiovascular (CV) risk-prone patients are easy to recognise, for example following manifestations of cardiovascular disease (CVD), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) interventions, and they deserve appropriate risk-factor control for secondary prevention, including blood pressure (BP) lowering. However, many other at-risk patients… View more
Author(s): Simona Giampaoli Added: 3 years ago
Primordial Prevention – What Does It Mean? In 1978, Strasser suggested that prevention of cardiovascular disease (CVD) should go beyond the concept of primary prevention. He coined the term ‘primordial prevention’ to denote activities that prevented the penetration of risk factors into the population1 by intervening to stop the appearance of the risk factors. The 3rd International Heart Health… View more
Author(s): Maura Marcucci Added: 2 years ago
In this short interview from our coverage of the ACC.22 late-breaking trials, Dr Maura Marcucci (McMaster University, ON, CA) discusses a sub-study of the POISE-3 trial, which sought to evaluate the effects of a perioperative hypotension-avoidance strategy, compared to a hypertension-avoidance strategy in patients undergoing non-cardiac surgery (NCT03505723). Discussion Points: Study… View more
Author(s): Michel Burnier Added: 3 years ago
Hypertension (HTN) is the most prevalent cardiovascular risk factor in developed and developing countries.1 According to most recent guidelines, the goal of HTN management should be to reduce blood pressure (BP) to <140/90mmHg and even lower in patients with a high cardiovascular risk in order to lower the incidence of cardiovascular events such as stroke, myocardial infarction, congestive… View more
Author(s): Kazem Rahimi Added: 7 years ago
Associate Professor Kazem Rahimi discusses "Blood pressure lowering for prevention of cardiovascular disease and death" at the 2016 ESC Congress in Rome, Italy. View more